Matches in Wikidata for { <http://www.wikidata.org/entity/Q91933939> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- Q91933939 description "article scientifique publié en 2019" @default.
- Q91933939 description "artículu científicu espublizáu en marzu de 2019" @default.
- Q91933939 description "scientific article published on 23 March 2019" @default.
- Q91933939 description "wetenschappelijk artikel" @default.
- Q91933939 description "наукова стаття, опублікована 23 березня 2019" @default.
- Q91933939 name "The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer" @default.
- Q91933939 name "The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer" @default.
- Q91933939 type Item @default.
- Q91933939 label "The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer" @default.
- Q91933939 label "The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer" @default.
- Q91933939 prefLabel "The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer" @default.
- Q91933939 prefLabel "The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer" @default.
- Q91933939 P1433 Q91933939-EED5D757-67F9-4A47-BBF8-DF0D7A988D0B @default.
- Q91933939 P1476 Q91933939-9896597C-A35A-4918-8E6E-25ADE4E6BC4D @default.
- Q91933939 P2093 Q91933939-02C512FE-A36C-4020-B8B2-63E80BEC06A9 @default.
- Q91933939 P2093 Q91933939-0AF1D72F-4AFC-4A3C-A5DA-6E1EC0C69AC4 @default.
- Q91933939 P2093 Q91933939-0B2F8978-F546-4ABA-9318-FAF674953C2C @default.
- Q91933939 P2093 Q91933939-350BA0D3-3B58-4F08-B22E-AD97187D9F12 @default.
- Q91933939 P2093 Q91933939-3F23F590-77B5-4CEF-BB16-56B0B58BA951 @default.
- Q91933939 P2093 Q91933939-5D4362B5-EE2E-4665-83B8-3365CE0B3930 @default.
- Q91933939 P2093 Q91933939-628DE89D-5244-4C95-BCA2-525DDB608708 @default.
- Q91933939 P2093 Q91933939-6EFD4ED4-0316-48D4-AFF8-3410C0901032 @default.
- Q91933939 P2093 Q91933939-7F159D42-737F-4011-B1E0-7AD32BC9123E @default.
- Q91933939 P2093 Q91933939-85368082-1C1A-4454-803A-CA41519073E5 @default.
- Q91933939 P2093 Q91933939-85A3A1FC-2FA8-43A9-BD40-0C70047898FA @default.
- Q91933939 P2093 Q91933939-AB4B803A-74A8-4B47-B840-D8BDA07A74C3 @default.
- Q91933939 P2093 Q91933939-AEBE2C4B-E738-4D48-A7DC-C38CA789A1CF @default.
- Q91933939 P2093 Q91933939-C7354711-73CC-402E-82F3-43066803FF7F @default.
- Q91933939 P2093 Q91933939-CC01851A-D19C-4125-9240-EE67D93D5C41 @default.
- Q91933939 P2093 Q91933939-D9F3AB47-AE69-4D4B-A7A0-02395290ED72 @default.
- Q91933939 P2093 Q91933939-EB20AE8C-FA54-454A-A32B-6D33C2445D7A @default.
- Q91933939 P2093 Q91933939-F8AE100F-1E7A-4A13-96AA-00E253E8C99D @default.
- Q91933939 P2093 Q91933939-FE4B44E3-57BA-4910-9C02-D7149344603B @default.
- Q91933939 P304 Q91933939-FFA7A3CF-8792-4B1F-8739-1CD77457DF6C @default.
- Q91933939 P31 Q91933939-F597F143-7CDC-490D-A6B4-834D2CB67391 @default.
- Q91933939 P356 Q91933939-0A6A2F65-2B6F-4F36-94FE-0AE43FAFCC68 @default.
- Q91933939 P407 Q91933939-683DCE0D-F2ED-4FE4-B4B7-24BAEED15814 @default.
- Q91933939 P433 Q91933939-5B55DA8F-6765-46BE-823E-6FC37C0740F6 @default.
- Q91933939 P478 Q91933939-60FC026B-5075-48E5-8049-33488C548FDB @default.
- Q91933939 P50 Q91933939-D5DB3C49-90A4-4628-A0FA-EA4F957C91AA @default.
- Q91933939 P577 Q91933939-774475E0-B0A5-4243-843B-E31622B2F4A7 @default.
- Q91933939 P698 Q91933939-0929FE3D-3492-4B33-BE3B-C76E68F5A5DD @default.
- Q91933939 P921 Q91933939-0C40B06D-2D37-4EE3-A3AA-7A326B847D51 @default.
- Q91933939 P356 IJC.32238 @default.
- Q91933939 P698 30807643 @default.
- Q91933939 P1433 Q332492 @default.
- Q91933939 P1476 "The influence of treatment sequence in the prognostic value of TMPRSS2-ERG as biomarker of taxane resistance in castration-resistant prostate cancer" @default.
- Q91933939 P2093 "Albert Font" @default.
- Q91933939 P2093 "Aleix Prat" @default.
- Q91933939 P2093 "Alejo Rodríguez-Vida" @default.
- Q91933939 P2093 "Aránzazu González Del Alba" @default.
- Q91933939 P2093 "Cristina Suárez" @default.
- Q91933939 P2093 "Geòrgia Anguera" @default.
- Q91933939 P2093 "Iván Victoria" @default.
- Q91933939 P2093 "Joan Carles" @default.
- Q91933939 P2093 "Maria José Ribal" @default.
- Q91933939 P2093 "Maria Milà-Guasch" @default.
- Q91933939 P2093 "Mercedes Marín-Aguilera" @default.
- Q91933939 P2093 "Montserrat Domènech" @default.
- Q91933939 P2093 "Natalia Jiménez" @default.
- Q91933939 P2093 "Núria Sala-González" @default.
- Q91933939 P2093 "Olatz Etxaniz" @default.
- Q91933939 P2093 "Pablo Maroto" @default.
- Q91933939 P2093 "Pedro Luis Fernández" @default.
- Q91933939 P2093 "Sandra López" @default.
- Q91933939 P2093 "Òscar Reig" @default.
- Q91933939 P304 "1970-1981" @default.
- Q91933939 P31 Q13442814 @default.
- Q91933939 P356 "10.1002/IJC.32238" @default.
- Q91933939 P407 Q1860 @default.
- Q91933939 P433 "7" @default.
- Q91933939 P478 "145" @default.
- Q91933939 P50 Q91933929 @default.
- Q91933939 P577 "2019-03-23T00:00:00Z" @default.
- Q91933939 P698 "30807643" @default.
- Q91933939 P921 Q864574 @default.